Glycoprotein IIb/IIIa inhibitors for cardiogenic shock complicating acute myocardial infarction: a systematic review, meta-analysis, and meta-regression

Glycoprotein IIb/IIIa inhibitors for cardiogenic shock complicating acute myocardial infarction: a systematic review, meta-analysis, and meta-regression

Abstract Background Cardiogenic shock complicates 5–10% of myocardial infarction (MI) cases. Data about the benefit of glycoprotein IIb/IIIa inhibitors (GPI) in these patients is sparse and conflicting. Methods We performed a systematic review, meta-analysis, and meta-regression of studies assessing...

Full description

Bibliographic Details
Main Authors: Carolina Saleiro, Rogério Teixeira, Diana De Campos, João Lopes, Bárbara Oliveiros, Marco Costa, Lino Gonçalves
Format: Article
Language:English
Published: BMC 2020-11-01
Series:Journal of Intensive Care
Subjects:
Glycoprotein IIb/IIIa inhibitors
Abciximab
Eptifibatid
Cardiogenic shock
Online Access:http://link.springer.com/article/10.1186/s40560-020-00502-y

Internet

http://link.springer.com/article/10.1186/s40560-020-00502-y

Similar Items